Cargando…

Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion

INTRODUCTION: Tumor-associated macrophages are one of the key components of the tumor microenvironment. The immunomodulatory activity and function of macrophages in malignant pleural effusion (MPE), a special tumor metastasis microenvironment, have not been clearly defined. METHODS: MPE-based single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Ming-Ming, Pei, Xue-Bin, Chen, Qing-Yu, Wang, Feng, Wang, Zhen, Zhai, Kan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151820/ https://www.ncbi.nlm.nih.gov/pubmed/37143656 http://dx.doi.org/10.3389/fimmu.2023.1161375

Ejemplares similares

Complement regulatory proteins: Candidate biomarkers in differentiating tuberculosis pleural effusion
por: Tang, Huan, et al.
Publicado: (2023)

Single-cell analysis of diverse immune phenotypes in malignant pleural effusion
por: Huang, Zhong-Yin, et al.
Publicado: (2021)

Malignant pleural effusions: Differentiating pelvic malignancies
por: Sharma, Mukesh, et al.
Publicado: (2015)

Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
por: Shi, Xin‐Yu, et al.
Publicado: (2019)

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions
por: Wang, Maoshui, et al.
Publicado: (2014)

C1q(+) tumor-associated macrophages contribute to immunosuppression through fatty acid metabolic reprogramming in malignant pleural effusion
por: Zhang, Siyu, et al.
Publicado: (2023)

HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions
por: Soloff, Adam C., et al.
Publicado: (2020)

Interleukin 32 as a Potential Marker for Diagnosis of Tuberculous Pleural Effusion
por: Du, Juan, et al.
Publicado: (2022)

T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions
por: Roofchayee, Neda Dalil, et al.
Publicado: (2021)

Macrophages in malignant pleural effusions – alternatively activated tumor associated macrophages
por: Kaczmarek, Mariusz, et al.
Publicado: (2012)

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)

Use of Platelet Parameters in the Differential Diagnosis of Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Tuberculous Pleural Effusion
por: Ai, Ling, et al.
Publicado: (2022)

Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion
por: Bao, Quanlei, et al.
Publicado: (2020)

Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions
por: Liu, Ya-Lan, et al.
Publicado: (2016)

Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion
por: Zheng, Sheng-Cai, et al.
Publicado: (2023)

Score for Differentiating Pleural Tuberculosis from Malignant Effusion
por: González, Alejandra, et al.
Publicado: (2019)

Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
por: Li, Xinying, et al.
Publicado: (2021)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Malignant pleural effusion diagnosis and therapy
por: Yang, Liangliang, et al.
Publicado: (2023)

S100A9 Regulated M1/M2 Macrophage Polarization in Interleukin-10-Induced Promotion of Malignant Pleural Effusion
por: Pei, Xue-Bin, et al.
Publicado: (2023)

Management of Malignant Pleural Effusions
por: Villanueva, Andrew G.
Publicado: (2012)

Management of Malignant Pleural Effusions
por: Charpidou, Adrianni, et al.
Publicado: (2006)

Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions
por: Budna, Joanna, et al.
Publicado: (2018)

Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta‐analysis
por: Yang, Yuan, et al.
Publicado: (2022)

Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
por: Chen, Dawei, et al.
Publicado: (2018)

High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019)

Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis
por: Peng, Peng, et al.
Publicado: (2022)

Diagnostic value of medical thoracoscopy in malignant pleural effusion
por: Wu, Yan-Bing, et al.
Publicado: (2017)

Combined analysis of C-reactive protein in pleural fluid and serum is effective in the differential diagnosis of exudative pleural effusions
por: Qu, Shuo-Yao, et al.
Publicado: (2021)

Downregulation of miR-4772-3p promotes enhanced regulatory T cell capacity in malignant pleural effusion by elevating Helios levels
por: Yu, Wen-Qing, et al.
Publicado: (2019)

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
por: Al-aarag, Abdel-sadek Hamed, et al.
Publicado: (2019)

Management of malignant pleural effusion with different pleural catheters
por: Karapolat, Sami, et al.
Publicado: (2018)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
por: Korczynski, P, et al.
Publicado: (2009)

Corrigendum: Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
por: Chen, Dawei, et al.
Publicado: (2021)

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions
por: JI, QIAOYING, et al.
Publicado: (2014)

Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT
por: Zhang, Xirong, et al.
Publicado: (2018)

GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
por: Liu, Yongxia, et al.
Publicado: (2021)

Differentiation of malignant from benign pleural effusions based on artificial intelligence
por: Wang, Sufei, et al.
Publicado: (2023)

An Update in the Management of Malignant Pleural Effusion
por: Muduly, DK, et al.
Publicado: (2011)

Ferritin Assay in Malignant Pleural Effusion
por: Chung, Won-Tae, et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_2k8i9teildq7ba1ohi01grdhpn